Top Markets
Coin of the day
Glenmark Life Sciences Limited Glenmark Life Sciences Limited

Glenmark Life Sciences Limited

GLS
Rank in Stocks #7700
Glenmark Life Sciences Limited, an Indian entity established in Mumbai in 2011,... Glenmark Life Sciences Limited, an Indian entity established in Mumbai in 2011, specializes in the creation, manufacturing, and distribution of high-value active pharmaceutical ingredients (APIs). These APIs are utilized across a wide array of chronic therapeutic areas. The company's diverse portfolio includes compounds for managing cardiovascular diseases (e.g., Olmesartan, Rosuvastatin, Amiodarone), central nervous system conditions (such as Oxcarbazepine, Topiramate, Lacosamide), and diabetes (including Glimepiride, Teneligliptin, Linagliptin). Additionally, they produce APIs for pain management (Etoricoxib, Lornoxicam), gastro-intestinal disorders, anti-infective treatments, respiratory ailments, and anti-emetic applications, featuring products like Atovaquone, Fluconazole, and Esomeprazole Magnesium. Beyond API production, Glenmark Life Sciences offers contract development and manufacturing (CDMO) solutions to numerous multinational and specialty pharmaceutical firms. Operating as a subsidiary of Glenmark Pharmaceuticals Limited, the company exports its products worldwide, reaching markets in Europe, North America, Latin America, and Japan.
Share Price
$12.18
Last synced: 2025-02-17
Market Cap
$1.49B
Change (1 day)
4.21%
Change (1 year)
0.00%
Country
IN
Trade Glenmark Life Sciences Limited (GLS)

Category

Stock price history for Glenmark Life Sciences Limited (GLS)
Highest end of day price: $13.07 on 2025-02-01

Lowest end of day price: $9.63 on 2021-08-01
Stock price history of Glenmark Life Sciences Limited from 2021 to 2026
Annual Stock Price Performance
Year Performance
2025 8.46%
2024 56.27%
2023 49.21%
2022 -36.04%
2021 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$171.67 -
DE
$165.77 32.02%
DE
$37.84 25.57%
JP
$223.76 28.36%
CH
$21.19 17.04%
IN